APA (7th ed.) Citation

Cassidy, J., Douillard, J., Twelves, C., McKendrick, J. J., Scheithauer, W., Bustová, I., . . . Cowell, W. (2006). Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: The X-ACT trial. British Journal of Cancer, 94(8), 1122. https://doi.org/10.1038/sj.bjc.6603059

Chicago Style (17th ed.) Citation

Cassidy, J., et al. "Pharmacoeconomic Analysis of Adjuvant Oral Capecitabine Vs Intravenous 5-FU/LV in Dukes' C Colon Cancer: The X-ACT Trial." British Journal of Cancer 94, no. 8 (2006): 1122. https://doi.org/10.1038/sj.bjc.6603059.

MLA (9th ed.) Citation

Cassidy, J., et al. "Pharmacoeconomic Analysis of Adjuvant Oral Capecitabine Vs Intravenous 5-FU/LV in Dukes' C Colon Cancer: The X-ACT Trial." British Journal of Cancer, vol. 94, no. 8, 2006, p. 1122, https://doi.org/10.1038/sj.bjc.6603059.